Halozyme Therapeutics shares owned by Candriam Luxembourg S.C.A.
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Candriam Luxembourg S.C.A.
from 13F filings
Historical chart of Candriam Luxembourg S.C.A. investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Candriam Luxembourg S.C.A.
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $691k | 800 | 863.77 |
2023-09-30 | $339k | 400 | 847.82 |
2023-06-30 | $666k | 800 | 832.82 |
2023-03-31 | $625k | 800 | 780.58 |
2022-12-31 | $2.8M | 2.5k | 1117.87 |
More positions owned by Candriam Luxembourg S.C.A.
View all positions for Candriam Luxembourg S.C.A.